Ethic Inc. Has $130,000 Stake in Sotera Health Company $SHC

Ethic Inc. lessened its position in shares of Sotera Health Company (NASDAQ:SHC) by 25.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,498 shares of the company’s stock after selling 3,841 shares during the period. Ethic Inc.’s holdings in Sotera Health were worth $130,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in SHC. TPG GP A LLC acquired a new position in Sotera Health during the first quarter valued at approximately $79,126,000. Sculptor Capital LP boosted its holdings in shares of Sotera Health by 80.8% in the 1st quarter. Sculptor Capital LP now owns 9,037,511 shares of the company’s stock valued at $105,377,000 after purchasing an additional 4,037,511 shares in the last quarter. T. Rowe Price Investment Management Inc. increased its stake in shares of Sotera Health by 5.9% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 8,045,502 shares of the company’s stock valued at $93,811,000 after purchasing an additional 450,761 shares during the last quarter. Two Seas Capital LP increased its stake in shares of Sotera Health by 14.7% in the 1st quarter. Two Seas Capital LP now owns 3,321,136 shares of the company’s stock valued at $38,724,000 after purchasing an additional 425,000 shares during the last quarter. Finally, Nuveen LLC acquired a new position in shares of Sotera Health during the 1st quarter worth $4,433,000. Institutional investors and hedge funds own 91.03% of the company’s stock.

Insider Buying and Selling

In other news, Director Gtcr Investment Xi Llc sold 8,000,000 shares of the business’s stock in a transaction that occurred on Friday, September 5th. The shares were sold at an average price of $15.11, for a total value of $120,880,000.00. Following the transaction, the director owned 41,215,301 shares in the company, valued at approximately $622,763,198.11. The trade was a 16.26% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Michael P. Rutz sold 126,611 shares of the company’s stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $16.38, for a total transaction of $2,073,888.18. Following the completion of the sale, the insider directly owned 450,204 shares in the company, valued at approximately $7,374,341.52. This represents a 21.95% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 20,126,611 shares of company stock valued at $304,273,888 over the last ninety days. 47.55% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on SHC. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Sotera Health in a research note on Friday. Wall Street Zen raised shares of Sotera Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 16th. Finally, Barclays raised their price target on shares of Sotera Health from $17.00 to $19.00 and gave the company an “overweight” rating in a research note on Thursday, October 2nd. Four analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $17.20.

Sotera Health Stock Performance

Shares of Sotera Health stock opened at $16.60 on Friday. The stock has a market cap of $4.72 billion, a price-to-earnings ratio of 207.53 and a beta of 1.82. Sotera Health Company has a twelve month low of $9.53 and a twelve month high of $17.15. The company’s fifty day moving average is $16.13 and its 200 day moving average is $13.57. The company has a quick ratio of 2.23, a current ratio of 2.47 and a debt-to-equity ratio of 4.49.

Sotera Health (NASDAQ:SHC) last announced its earnings results on Friday, August 8th. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.17 by $0.03. Sotera Health had a return on equity of 39.42% and a net margin of 2.14%.The firm had revenue of $294.34 million for the quarter, compared to the consensus estimate of $275.81 million. During the same period in the previous year, the business earned $0.19 EPS. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. Sell-side analysts forecast that Sotera Health Company will post 0.61 EPS for the current year.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.